Inbiogen Overview
- Year Founded
-
2008
- Status
-
Public
- Employees
-
29
- Stock Symbol
-
101140
- Investments
-
3
- Share Price
-
$3.53
- (As of Tuesday Closing)
Inbiogen General Information
Description
Inbiogen is engaged in kiosk distribution and F&B business. The kiosk industry, which features payment functionality and the F&B business is engaged in restaurant.
Contact Information
Website
www.inbiogen.co.krCorporate Office
- 2nd floor, 21, Eonju-ro 135-gil
- Gangnam-gu
- Seoul
- South Korea
Corporate Office
- 2nd floor, 21, Eonju-ro 135-gil
- Gangnam-gu
- Seoul
- South Korea
Inbiogen Stock Performance
As of 17-Nov-2026, Inbiogen’s stock price is $3.53. Its current market cap is $35.2M with 10M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.53 | $3.54 | $3.13 - $9.43 | $35.2M | 10M | 3.78K | -$1.43 |
Inbiogen Financials Summary
As of 30-Jun-2026, Inbiogen has a trailing 12-month revenue of $3.52M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 38,358 | 72,650 | ||
| Revenue | 3,517 | 4,425 | 5,160 | 4,773 |
| EBITDA | (14,739) | (1,294) | 11,951 | 9,221 |
| Net Income | (14,282) | (997) | 11,816 | 8,677 |
| Total Assets | 95,190 | 111,106 | 110,477 | 113,064 |
| Total Debt | 2,624 | 811 | 607 | 460 |
Inbiogen Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Inbiogen Patents
Inbiogen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2025066744-A | Information processing device, information processing method, and program | Pending | 31-Aug-2023 | ||
| JP-2024159600-A | Course guide support system, course guide support method, and program | Active | 28-Apr-2023 | ||
| JP-2024070855-A | Information processing device, information processing system, and information processing method | Active | 11-Nov-2022 | ||
| JP-2022162668-A | Personnel management system, server, personnel management method, and program | Active | 13-Apr-2021 | ||
| JP-6674988-B2 | Simulation apparatus, simulation system, program, and simulation method | Active | 21-Sep-2018 |
Inbiogen Signals
Inbiogen Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Inbiogen Investments (3)
Inbiogen’s most recent deal was a PIPE with Vidente for . The deal was made on 28-Apr-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Vidente | 28-Apr-2022 | PIPE | Electronics (B2C) | ||
| Vidente | 30-Dec-2021 | PIPE | Electronics (B2C) | ||
| HaimBio | 20-Nov-2020 | Corporate | Biotechnology |
Inbiogen ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Technology Hardware
Industry
Rank
Percentile
Electronics Equipment
Subindustry
Rank
Percentile
Inbiogen Exits (1)
Inbiogen’s most recent exit was on 20-Nov-2020 from HaimBio. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| HaimBio | 20-Nov-2020 | Completed |
|
Inbiogen FAQs
-
When was Inbiogen founded?
Inbiogen was founded in 2008.
-
Where is Inbiogen headquartered?
Inbiogen is headquartered in Seoul, South Korea.
-
What is the size of Inbiogen?
Inbiogen has 29 total employees.
-
What industry is Inbiogen in?
Inbiogen’s primary industry is Computers, Parts and Peripherals.
-
Is Inbiogen a private or public company?
Inbiogen is a Public company.
-
What is Inbiogen’s stock symbol?
The ticker symbol for Inbiogen is 101140.
-
What is the current stock price of Inbiogen?
As of 17-Nov-2026 the stock price of Inbiogen is $3.53.
-
What is the current market cap of Inbiogen?
The current market capitalization of Inbiogen is $35.2M.
-
What is Inbiogen’s current revenue?
The trailing twelve month revenue for Inbiogen is $3.52M.
-
What is Inbiogen’s annual earnings per share (EPS)?
Inbiogen’s EPS for 12 months was -$1.43.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process